Cancer Risk

Analyst: MELA skin cancer device will get FDA nod
An researcher pronounced Friday which he expects MELA Sciences Inc.’s melanoma showing device to win regulatory capitulation early subsequent year, notwithstanding the behind review.

Cancer Topics: Analyst, Cancer, device, MELA, Melanoma, melanoma detection, regulatory approval, Skin, Skin Cancer